BRIEF published on 10/15/2024 at 07:03, 1 month 6 days ago DocMorris accélère la croissance des médicaments sur ordonnance Croissance Des Revenus Télésanté DocMorris AG Médicaments Sur Ordonnance Fermeture Logistique
BRIEF published on 10/15/2024 at 07:03, 1 month 6 days ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
PRESS RELEASE published on 10/15/2024 at 06:58, 1 month 6 days ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 3 months 1 day ago DocMorris améliore son activité de prescription et stimule les investissements de ses nouveaux clients en matière de prescription Perspectives 2024 Ordonnances Électroniques Doc Morris Entreprise De Prescription TéléClinique
BRIEF published on 08/20/2024 at 07:03, 3 months 1 day ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
PRESS RELEASE published on 08/20/2024 at 06:58, 3 months 1 day ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 4 months 10 days ago DocMorris annonce une croissance significative d'eRx au deuxième trimestre 2024 L'expansion Du Marché Augmentation Des Revenus DocMorris Croissance ERx
BRIEF published on 07/11/2024 at 07:03, 4 months 10 days ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
PRESS RELEASE published on 07/11/2024 at 06:58, 4 months 10 days ago DocMorris with accelerated and significant eRx growth in new customers, market share and revenue DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base Revenue Market Share DocMorris ERx Growth CardLink
BRIEF published on 05/23/2024 at 07:03, 5 months 29 days ago DocMorris AG annonce le remboursement anticipé d'obligations convertibles à 2,75 % Annonce Financière Liens Convertibles DocMorris AG Rédemption Anticipée Conversion D'obligations
Published on 11/21/2024 at 12:00, 1 hour 8 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 8 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 38 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 5 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 8 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:35, 33 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 53 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 38 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 10 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 1 minute ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 48 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
